Want to join the conversation?
$TMK 2Q15 Call: On the health side, premium revenue grew 8% to $232MM & health underwriting margin grew 4% to $52MM. Growth in underwriting margin lagged the growth in premium due to large amount of group business, which has lower margins than our other health business. For the full year, we expect health underwriting margin to increase 2% to 4%.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?